TSX futures inch lower after index closes at new all-time high
Harvard Apparatus Regenerative Technology (NASDAQ:HRGN), a $34.17 million market cap company, saw CEO He Junli report purchasing 11,225 shares of common stock on September 2, 2025, in one transaction. The stock has shown strong momentum with a 20.61% gain over the past week.
The purchase was made at $1.85 per share, totaling $20,766, with the stock now trading at $1.99. Following the transaction, He Junli directly owns 277,275 shares of Harvard Apparatus Regenerative Technology. According to InvestingPro, the stock typically moves opposite to the market with a beta of -0.31, while analysts project substantial revenue growth for FY2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.